BMSEED: News

BMSEED is committed to driving innovation and creating a positive impact on the biomedical research community. Our mission is to develop and provide state-of-the-art devices that empower researchers, biomedical scientists, and healthcare professionals to push the boundaries of scientific discovery. Through our cutting-edge technologies, including stretchable microelectrode arrays and advanced cell-stretching systems, we aim to facilitate more effective and efficient biomedical studies. Our focus is on supporting the advancement of biomedical science, fostering collaboration, and enabling groundbreaking research that can transform healthcare. Whether through partnerships, product innovation, or knowledge sharing, BMSEED is dedicated to shaping the future of biomedicine.

Reach Out to BMSEED

Contact us at BMSEED if you're interested in the MEASSuRE system. Our team will walk you through how this tool can support and enhance your research.

Oliver Graudejus 7/25/23 Oliver Graudejus 7/25/23

BMSEED Mentoring NIA Startup Challenge

BMSEED will be mentoring at the 2023 NIA Startup Challenge.

Oliver Graudejus 7/8/23 Oliver Graudejus 7/8/23

BMSEED's Product at the 28th Congress of the European Society of Biomechanics

BMSEED’s products will be featured at the 28th Congress of the European Society of Biomechanics in Maastricht, The Netherlands.

Oliver Graudejus 6/11/23 Oliver Graudejus 6/11/23

BMSEED at 2023 BRAIN Initiative Meeting

BMSEED is presenting our research products at the BRAIN Initiative Meeting on June 12 and 13, 2023.

Oliver Graudejus 3/23/23 Oliver Graudejus 3/23/23

BMSEED at 2023 Arizona BioPreneur Conference

BMSEED is presenting at the 2023 Arizona BioPreneur Conference in Downtown Phoenix, Arizona.

Oliver Graudejus 1/31/23 Oliver Graudejus 1/31/23

BMSEED filed non-provisional patent application for 3D microelectrode array technology

BMSEED filed a non-provisional patent application for 3D stretchable microelectrode array technology.

Oliver Graudejus 12/28/22 Oliver Graudejus 12/28/22

The Benefits and Advantages of Digital EEG

Discover the advantages of digital EEG. Contact BMSEED for more information on in-vivo brain research applications of electroencephalograms.

Oliver Graudejus 11/17/22 Oliver Graudejus 11/17/22

What Exactly Is Alzheimer’s Disease?

Discover facts regarding Alzheimer’s disease and how far scientists have progressed to combat the illness. Contact BMSEED for more information.

Oliver Graudejus 11/7/22 Oliver Graudejus 11/7/22

BMSEED at the Society for Neuroscience Annual Meeting

BMSEED will be exhibiting at the 2022 Society for Neuroscience conference in San Diego, California.

Oliver Graudejus 10/24/22 Oliver Graudejus 10/24/22

What is World Spine Day?

World Spine Day takes place as part of Bone and Joint Decade Action Week to increase awareness regarding spinal health and related problems like spinal cord injuries.

Oliver Graudejus 10/17/22 Oliver Graudejus 10/17/22

BMSEED at 3rd Symposium on Stem Cell Biology and Regenerative Medicine

The talk is titled “‘Expanding the toolkit of biomedical engineers: Stretchable microelectrodes for in vitro and in vivo applications”.

Oliver Graudejus 9/20/22 Oliver Graudejus 9/20/22

BMSEED Awarded Fast Track SBIR Grant from NIH

BMSEED was awarded a Fast Track SBIR grant from NIH to develop and commercialize a microfluidic chip-based platform for modeling Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD) for preclinical in vitro mechanistic studies and drug testing.

Oliver Graudejus 6/27/22 Oliver Graudejus 6/27/22

BMSEED files non-provisional patent application for novel peripheral nerve interface

The mcPNI enables reliable, long-term neuromodulation in small peripheral nerves, and integrates a 2-photon 3D printed microclip with BMSEED’s stretchable microelectrode array (sMEA) technology.

Oliver Graudejus 6/1/22 Oliver Graudejus 6/1/22

BMSEED Chooses Intellectual Property Law Firm BSKB

BMSEED was recently awarded $50,000 from the NIH Small Business Phase II Technical and Business Assistance (TABA) Consulting Services program with the goal to strengthen the company’s IP portfolio.